Breaking storiesBreaking stories›TQ: Merck, Moderna report positive melanoma vaccine trial results
Updated
Daily Attention
TQ: Merck, Moderna report positive melanoma vaccine trial results
TQ
Sensation developed Aug 19
last headline Aug 19
covered in 4 of 8 regions
8 sources reporting
first picked up in Africa
reached 4 regions in 46 min
'cancer vaccine' recurs across headlines
Sensation developed Aug 19
8Headlines
4 sourcesSame headline
Lovande resultat för behandling av svår hudcancer
(first reported)
Hindustan Times (India)
Moderna stock jumps 120% after cancer vaccine trial win: What investors need to know
South China Morning Post (Hong Kong)
Merck, Moderna claim encouraging melanoma vaccine trial results
The Hill (United States)
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning
Citizen Digital (Kenya)
Merck, Moderna claim 'promising' skin cancer vaccine results in key trial
TQ
Summarization
Sources reported that Merck and Moderna announced positive results from a late-stage trial of their experimental melanoma vaccine used with Merck's Keytruda treatment.
Suggested Google searches
Created